1MED at OCT Medical Devices Europe 2026

1MED is pleased to announce its participation in OCT Medical Devices Europe 2026, one of the leading European events dedicated to medical device development, clinical evidence, and regulatory strategy. The event will take place from January 27 – 28, 2026, at the Holiday Inn Munich City Centre in Munich, Germany, bringing together manufacturers, regulators, and industry experts to discuss the future of medical devices in Europe.

OCT Medical Devices Europe is a key forum for addressing current and upcoming challenges under the EU MDR, with a strong focus on clinical evidence generation, post-market clinical follow-up (PMCF), and Notified Body expectations. The 2026 edition will place particular emphasis on how manufacturers can build robust, regulator-aligned clinical strategies that are sustainable over time.

A Spotlight on Strategic PMCF

Our experts will actively contribute to the conference program, sharing hands-on insights derived from ongoing MDR projects. A highlight of our participation will be a session delivered by 1MED Founder, Enrico Perfler.

On January 27th, Enrico will hold a speech titled:

“From PMCF obligation to strategic advantage: standardising PMCF under EU MDR with 1Survey+”

This session will explore practical approaches to transforming regulatory obligations into valuable data assets, streamlining compliance while gaining a strategic edge.

Meet Us at Booth 7

Throughout the event, the 1MED team will be available at Booth 7 to meet with attendees and exchange perspectives on MDR evidence generation, PMCF strategy, and the practical realities of clinical and regulatory compliance. We look forward to discussing your current challenges and identifying opportunities to strengthen your clinical and regulatory approach.

We look forward to connecting with industry peers and partners at OCT Medical Devices Europe 2026 in Munich.

Let’s Connect

Are you planning to attend? We would love to schedule a dedicated time to speak with you in Munich.

Book a meeting with us at the event

More insights

1Survey+

The first clinical-grade platform
for PMCF and Real-World Evidence.